Condition
Adult Solid Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Adult Solid Tumor clinical trials that are recruiting, at sites in 10 countries (most in Germany (2), Italy (2), Poland (2)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 10Countries
Newest Adult Solid Tumor clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Visugromab plus nivolumab, with or without docetaxel, for second-line treatment of metastatic non-squamous non-small cell lung cancer | Phase 2 | Birmingham, Alabama and 35 other locations | Recruiting | Nov 24, 2025 |
| Visugromab added to first-line immunochemotherapy for metastatic non-squamous NSCLC | Phase 2 | Birmingham, Alabama and 50 other locations | Recruiting | Aug 1, 2025 |
| Testing the safety and effects of DO-2 in patients with advanced solid tumors | Phase 1 | Brussels and 12 other locations | Recruiting | Mar 2, 2023 |
All recruiting trials (3)
-
Visugromab plus nivolumab, with or without docetaxel, for second-line treatment of metastatic non-squamous non-small cell lung cancer
This trial tests whether adding the anti-GDF-15 antibody visugromab to nivolumab, with or without docetaxel, helps people with metastatic non-squamous NSCLC whose cancer progressed after first-line treatment that included a checkpoint inhibitor.
-
Visugromab added to first-line immunochemotherapy for metastatic non-squamous NSCLC
This trial tests whether adding visugromab to standard immunochemotherapy (pembrolizumab, pemetrexed, carboplatin) helps people with newly diagnosed metastatic non-squamous NSCLC who do not have targetable mutations.
-
Testing the safety and effects of DO-2 in patients with advanced solid tumors
This study is testing a new drug called DO-2 to see if it's safe and how it works for people with advanced solid tumors that have specific genetic changes.
Related topics
Quick answers
How many Adult Solid Tumor clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in Germany (2 trials), Italy (2 trials), Poland (2 trials), Romania (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.